These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 19501658)
1. Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs). Harris RE; Zubieta JK; Scott DJ; Napadow V; Gracely RH; Clauw DJ Neuroimage; 2009 Sep; 47(3):1077-85. PubMed ID: 19501658 [TBL] [Abstract][Full Text] [Related]
2. Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Schrepf A; Harper DE; Harte SE; Wang H; Ichesco E; Hampson JP; Zubieta JK; Clauw DJ; Harris RE Pain; 2016 Oct; 157(10):2217-2225. PubMed ID: 27420606 [TBL] [Abstract][Full Text] [Related]
3. Decreased central mu-opioid receptor availability in fibromyalgia. Harris RE; Clauw DJ; Scott DJ; McLean SA; Gracely RH; Zubieta JK J Neurosci; 2007 Sep; 27(37):10000-6. PubMed ID: 17855614 [TBL] [Abstract][Full Text] [Related]
4. Low- and high-frequency transcutaneous electrical acupoint stimulation induces different effects on cerebral μ-opioid receptor availability in rhesus monkeys. Xiang XH; Chen YM; Zhang JM; Tian JH; Han JS; Cui CL J Neurosci Res; 2014 May; 92(5):555-63. PubMed ID: 24482187 [TBL] [Abstract][Full Text] [Related]
5. Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report. DosSantos MF; Martikainen IK; Nascimento TD; Love TM; DeBoer MD; Schambra HM; Bikson M; Zubieta JK; DaSilva AF PLoS One; 2014; 9(7):e102350. PubMed ID: 25029273 [TBL] [Abstract][Full Text] [Related]
6. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260 [TBL] [Abstract][Full Text] [Related]
7. Expectancy and treatment interactions: a dissociation between acupuncture analgesia and expectancy evoked placebo analgesia. Kong J; Kaptchuk TJ; Polich G; Kirsch I; Vangel M; Zyloney C; Rosen B; Gollub R Neuroimage; 2009 Apr; 45(3):940-9. PubMed ID: 19159691 [TBL] [Abstract][Full Text] [Related]
8. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia. Sun J; Chen SR; Chen H; Pan HL J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671 [TBL] [Abstract][Full Text] [Related]
9. Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids. Lamusuo S; Hirvonen J; Lindholm P; Martikainen IK; Hagelberg N; Parkkola R; Taiminen T; Hietala J; Helin S; Virtanen A; Pertovaara A; Jääskeläinen SK Eur J Pain; 2017 Oct; 21(9):1505-1515. PubMed ID: 28493519 [TBL] [Abstract][Full Text] [Related]
10. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms. Nuechterlein EB; Ni L; Domino EF; Zubieta JK Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017 [TBL] [Abstract][Full Text] [Related]
11. Response of the μ-opioid system to social rejection and acceptance. Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Wang H; Ni L; Walker SJ; Mickey BJ; Korycinski ST; Koeppe RA; Crocker JK; Langenecker SA; Zubieta JK Mol Psychiatry; 2013 Nov; 18(11):1211-7. PubMed ID: 23958960 [TBL] [Abstract][Full Text] [Related]
12. Placebo effects on human mu-opioid activity during pain. Wager TD; Scott DJ; Zubieta JK Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11056-61. PubMed ID: 17578917 [TBL] [Abstract][Full Text] [Related]
13. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Ray R; Ruparel K; Newberg A; Wileyto EP; Loughead JW; Divgi C; Blendy JA; Logan J; Zubieta JK; Lerman C Proc Natl Acad Sci U S A; 2011 May; 108(22):9268-73. PubMed ID: 21576462 [TBL] [Abstract][Full Text] [Related]